ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726771 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726771; 2) Community: the network communities that were significantly associated with the response to NSC 726771; 3) Molecule: the relationships between components within communities and NSC 726771; 4) MDR: the compounds that were significantly associated with the NSC 726771.

NSC Compound Enrichment Correlation
NSC 618939 Camptothecin Derivative 0.00863223795880985 0.47843082
NSC 619688 Null 0.00863223795880985 0.34216452
NSC 646847 Bengamide G 0.00863223795880985 0.45406476
NSC 692638 Null 0.00863223795880985 0.47585495
NSC 695590 Null 0.00863223795880985 0.26775354
NSC 695941 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate 0.00863223795880985 0.60582409
NSC 707484 Null 0.00863223795880985 -0.11442197
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00863223795880985 0.56890109
NSC 735037 Camptothecin Derivative 0.00863223795880985 0.44020831
NSC 757387 ACRIFLAVINIUM HYDROCHLORIDE 0.00863223795880985 0.30579692
Total:45  Current:9    [First] [Prev] [Next] [Last]